Quarterly Consolidated Balance Sheet

KYORIN Pharmaceutical Co., Ltd. - Filing #7573971

Concept As at
2022-12-31
As at
2022-03-31
Quarterly consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,713,000,000 JPY
26,994,000,000 JPY
Securities
JPY
500,000,000 JPY
Merchandise and finished goods
21,104,000,000 JPY
19,038,000,000 JPY
Work in process
11,150,000,000 JPY
7,742,000,000 JPY
Raw materials and supplies
16,296,000,000 JPY
15,437,000,000 JPY
Other
3,666,000,000 JPY
5,029,000,000 JPY
Allowance for doubtful accounts
-38,000,000 JPY
-39,000,000 JPY
Current assets
114,643,000,000 JPY
116,376,000,000 JPY
Non-current assets
Property, plant and equipment
26,392,000,000 JPY
24,334,000,000 JPY
Property, plant and equipment
Intangible assets
Intangible assets
5,335,000,000 JPY
3,289,000,000 JPY
Investments and other assets
28,190,000,000 JPY
27,923,000,000 JPY
Investments and other assets
Investment securities
26,272,000,000 JPY
25,703,000,000 JPY
Deferred tax assets
483,000,000 JPY
783,000,000 JPY
Other
1,468,000,000 JPY
1,475,000,000 JPY
Allowance for doubtful accounts
-33,000,000 JPY
-38,000,000 JPY
Non-current assets
59,919,000,000 JPY
55,547,000,000 JPY
Assets
174,562,000,000 JPY
171,924,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
10,973,000,000 JPY
10,896,000,000 JPY
Short-term borrowings
10,300,000,000 JPY
10,300,000,000 JPY
Income taxes payable
893,000,000 JPY
530,000,000 JPY
Other
9,108,000,000 JPY
8,159,000,000 JPY
Current liabilities
32,993,000,000 JPY
32,182,000,000 JPY
Non-current liabilities
Long-term borrowings
10,686,000,000 JPY
10,836,000,000 JPY
Retirement benefit liability
2,675,000,000 JPY
2,885,000,000 JPY
Other
867,000,000 JPY
993,000,000 JPY
Non-current liabilities
14,780,000,000 JPY
15,234,000,000 JPY
Liabilities
47,773,000,000 JPY
47,416,000,000 JPY
Net assets
Shareholders' equity
Share capital
700,000,000 JPY
700,000,000 JPY
Capital surplus
4,752,000,000 JPY
4,752,000,000 JPY
Retained earnings
134,064,000,000 JPY
132,710,000,000 JPY
Treasury shares
-17,666,000,000 JPY
-17,671,000,000 JPY
Shareholders' equity
121,850,000,000 JPY
120,491,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
6,612,000,000 JPY
6,268,000,000 JPY
Foreign currency translation adjustment
413,000,000 JPY
110,000,000 JPY
Remeasurements of defined benefit plans
-2,087,000,000 JPY
-2,362,000,000 JPY
Valuation and translation adjustments
4,938,000,000 JPY
4,016,000,000 JPY
Net assets
126,788,000,000 JPY
124,507,000,000 JPY
Liabilities and net assets
174,562,000,000 JPY
171,924,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.